Evidence map›Paper›PMID 20957102›Full record

ArticleInternational journal of molecular sciences2010

Inhibitory activities of cyanidin and its glycosides and synergistic effect with acarbose against intestinal α-glucosidase and pancreatic α-amylase.

Sarinya Akkarachiyasit, Piyawan Charoenlertkul, Sirintorn Yibchok-Anun, Sirichai Adisakwattana

Open access · goldAbstract read
In one paragraph

Article in International journal of molecular sciences, 2010. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 74 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
74citing papers in PubMed, 1 pooled it
4.4field-weighted citation impact, top 5% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

74 citing papers in PubMed, 1 synthesis or guideline pooled it, 251 citations in OpenAlex.

  1. Pooled it
  2. Trial
  3. Trial
  4. Trial
  5. Trial
  6. Heterologous Expression ofPlants (Basel, Switzerland) · 2026
    Article
  7. Article
  8. Acute Effects ofFoods (Basel, Switzerland) · 2026
    Article
  9. Article
  10. Review
  11. Review
  12. Structure-effect relationship of phenolic compounds onCurrent research in food science · 2026
    Article
  13. Review
  14. Article
  15. Review
  16. Protective Effects of Isolated Curcumin FromJournal of diabetes research · 2025
    Article
  17. Review
  18. Antioxidant and Antidiabetic Activity ofMolecules (Basel, Switzerland) · 2024
    Article
  19. Review
  20. Review

14 more citing papers are in PubMed but not listed here.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors at 3 institutions in 4 countries.

Sarinya AkkarachiyasitDepartment of Pharmacology, Faculty of Veterinary Science, Chulalongkorn University, Bangkok 10330, Thailand; E-Mails: akkara_sarin@hotmail.com (S.A.); piyawanch@yahoo.com (P.C.); sirintorn.y@chula.ac.th (S.Y.).
Piyawan Charoenlertkul
Sirintorn Yibchok-Anun
Sirichai Adisakwattana
Chulalongkorn University · THAksaray University · TRSprint (United States) · US

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Cyanidin and its glycosides are naturally dietary pigments which have been indicated as promising candidates to have potential benefits to humans, especially in the prevention and treatment of diabetes mellitus. We investigated the structure activity relationships of cyanidin and its glycosides to inhibit intestinal α-glucosidases and pancreatic α-amylase in vitro. The results found that cyanidin and its glycosides are more specific inhibitors of intestinal sucrase than intestinal maltase. Cyanidin-3-galactoside and cyanidin-3-glucoside were the most potent inhibitors against intestinal sucrase and pancreatic α-amylase with IC(50) values of 0.50 ± 0.05 and 0.30 ± 0.01 mM, respectively. Our findings indicate that the structural difference between glucose and galactose at the 3-O-position of cyanidin was an important factor for modulating the inhibition of intestinal sucrase and pancreatic α-amylase. The combination of cyandin-3-glucoside, cyanidin-3- galactoside or cyanidin-3,5-diglucosides with a low concentration of acarbose showed synergistic inhibition on intestinal maltase and sucrase. The synergistic inhibition was also found for a combination of cyanidin or cyanidin-3-glucoside with a low concentration of acarbose. The findings could provide a new insight into a use for the naturally occurring intestinal α-glucosidase and pancreatic α-amylase inhibitors for the prevention and treatment of diabetes and its complications.

Indexed as

Glycoside Hydrolase InhibitorsAcarbosealpha-GlucosidasesAnimalsAnthocyaninsDrug SynergismEnzyme InhibitorsGlycosidesIntestinesPancreatic alpha-AmylasesRatsSubstrate SpecificitySwineAcarbosealpha-GlucosidasesAnthocyaninscyanidinEnzyme InhibitorsGlycoside Hydrolase InhibitorsGlycosidesPancreatic alpha-Amylasescyanidin glycosidesintestinal α-glucosidasepancreatic α-amylasesynergism

Identifiers

PMID20957102
PMCPMC2956102
OpenAlexW2005076106

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.